SRRK
NASDAQ
US
Scholar Rock Holding Corporation - Common Stock
$50.01
▲ +$0.66
(+1.34%)
Vol 2.0M
4
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$4.5B
ROE
-122.0%
Margin
-237.0%
D/E
40.66
Beta
0.67
52W
$23–$48
Wall Street Consensus
22 analysts · Apr 20269
Strong Buy
12
Buy
1
Hold
0
Sell
0
Strong Sell
95.5%
Buy Rating
Price Chart
Similar Stocks
KYMR
Kymera Therapeutics Inc
$6.1B
ACLX
Arcellx Inc
$3.8B
PTGX
Protagonist Therapeutics Inc
P/E 118.9
$5.5B
RYTM
Rhythm Pharmaceuticals Inc
$7.1B
COGT
Cogent Biosciences Inc
$5.4B
CGON
CG Oncology Inc
$3.3B
MIRM
Mirum Pharmaceuticals Inc
$4.1B
PTCT
PTC Therapeutics Inc
P/E 8.1
$6.1B
ERAS
Erasca Inc
$1.1B
CAI
Caris Life Sciences Inc
$7.6B
Earnings
Beat rate: 50.0%
Next Report
May 12, 2026
EPS Estimate: $-0.83
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.83 | — | — |
| Dec 2025 | $-0.91 | $-0.88 | +$0.03 |
| Sep 2025 | $-0.86 | $-0.90 | $-0.04 |
| Jun 2025 | $-0.68 | $-0.98 | $-0.30 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -126.9% | -127.1% | -127.1% | -127.1% | -126.9% | -122.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -237.0% | -237.0% | -237.0% | -237.0% | -237.0% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 21.33 | 21.33 | 21.33 | 21.33 | 21.33 | 40.66 |
| Current Ratio | 6.33 | 6.33 | 6.33 | 6.33 | 6.33 | 6.30 |
Key Ratios
ROA (TTM)
-86.5%
P/S (TTM)
95.00
P/B
11.0
EPS (TTM)
$-3.15
CF/Share
$-1.95
52W High
$48.28
52W Low
$22.71
$22.71
52-Week Range
$48.28
How does SRRK compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
SRRK valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
95.0
▲
639%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
11.0
▲
346%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
SRRK profitability vs Biotechnology peers
ROE
-122.0%
▼
81%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-237.0%
▲
17%
above
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-86.5%
▼
85%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
SRRK financial health vs Biotechnology peers
D/E ratio
40.7
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
6.3
▲
42%
above
peers
(4.4)
vs Peers
vs Industry
Below avg
Beta
0.7
▼
31%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
SRRK fundamentals radar
SRRK
Peer median
Industry
SRRK profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
SRRK vs peers: key metrics
Latest News
No related news yet